Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - candesartan cilexetil, quantity: 16 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: magnesium stearate; carrageenan; lactose monohydrate; maize starch; iron oxide red; croscarmellose sodium; povidone; iron oxide yellow - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - topiramate, quantity: 200 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; macrogol 400 - epilepsy: topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy, - for conversion to monotherapy in patients with epilepsy, and - as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine: topiramate is indicated for the prophylaxis of migraine headache in adults.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - topiramate, quantity: 100 mg - tablet, film coated - excipient ingredients: magnesium stearate; pregelatinised maize starch; sodium starch glycollate; microcrystalline cellulose; lactose monohydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - epilepsy: topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy, - for conversion to monotherapy in patients with epilepsy, and - as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine: topiramate is indicated for the prophylaxis of migraine headache in adults.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - topiramate, quantity: 50 mg - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; sodium starch glycollate; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; macrogol 400 - epilepsy: topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy, - for conversion to monotherapy in patients with epilepsy, and - as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine: topiramate is indicated for the prophylaxis of migraine headache in adults.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - topiramate, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate; microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - epilepsy: topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy, - for conversion to monotherapy in patients with epilepsy, and - as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine: topiramate is indicated for the prophylaxis of migraine headache in adults.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - topiramate, quantity: 200 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; lactose; saccharin sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; xanthan gum; polyvinyl alcohol; iron oxide black; lecithin; flavour - epilepsy (adults and children 2 years and over),? monotherapy in patients with newly diagnosed epilepsy,? conversion to monotherapy in patients with epilepsy,? add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome.,migraine (adult),prophylaxis of migraine headache in adults. the usefulness of topiramate in the acute treatment of migraine headache has not been studied.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - topiramate, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; lactose; saccharin sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; xanthan gum; polyvinyl alcohol; iron oxide black; lecithin; flavour - epilepsy (adults and children 2 years and over),? monotherapy in patients with newly diagnosed epilepsy,? conversion to monotherapy in patients with epilepsy,? add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome.,migraine (adult),prophylaxis of migraine headache in adults. the usefulness of topiramate in the acute treatment of migraine headache has not been studied.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - topiramate, quantity: 25 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; lactose; saccharin sodium; magnesium stearate; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin; flavour - epilepsy (adults and children 2 years and over),? monotherapy in patients with newly diagnosed epilepsy,? conversion to monotherapy in patients with epilepsy,? add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome.,migraine (adult),prophylaxis of migraine headache in adults. the usefulness of topiramate in the acute treatment of migraine headache has not been studied.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: iron oxide red; iron oxide yellow; croscarmellose sodium; silicon dioxide; carnauba wax; lactose monohydrate; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; macrogol 3350; iron oxide black - karvezide is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: silicon dioxide; microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; iron oxide yellow; magnesium stearate; carnauba wax; croscarmellose sodium; iron oxide red; titanium dioxide; hypromellose; macrogol 3350; iron oxide black - avapro hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.